Clinical trial NCT00962624 - References

Meningococcal Meningitis, Serogroup A — Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults

Citation(s)

•   Findlow J, Bai X, Findlow H, Newton E, Kaczmarski E, Miller E, Borrow R
  Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workers. Vaccine. 2015 Jun 26;33(29):3322-30. doi: 10.1016/j.vaccine.2015.05.027. Epub 2015 May 27.

A Phase 2, Open-label Study of the Safety, Tolerability and Immunogenicity of a Meningococcal B Vaccine When Administered at a 0, 2, 6 Months and of a Single Dose of Meningococcal ACWY Conjugate Vaccine in Healthy Adults Aged 18-65 Years

Details for clinical trial NCT00962624